Billerica, Massachusetts, March 6, 2017 — MilliporeSigma today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation. This launch marks 50 years of providing ultrapure water to scientists in laboratories all over the world. The company announced details about the water purification system during a press briefing at the Pittcon Conference & Expo 2017 in Chicago, Illinois.
“While there have been tremendous advancements in the lab, today’s scientists continue to seek ways to improve reproducibility and reliability of data,” said Udit Batra, Member of the Executive Board, Merck KGaA, Darmstadt, Germany and CEO, MilliporeSigma. “Our customers are looking for compact, ergonomic systems and software so that they can advance science, further faster. Our new lab water system addresses these pain points, allowing scientists to focus on problem solving, without worrying about the purity of their water. This new system reflects our legacy of pioneering innovations in lab water purification.”
For half a century, MilliporeSigma has been the partner of choice for water purification systems and services for lab scientists who need to ensure their water is free of contaminants.
To ensure that MilliporeSigma’s new water purification systems meet customers’ evolving needs, the company combined customer feedback with its engineering and technical expertise to develop the Milli-Q® IQ 7000 system—an even smaller, easier-to-use, device, designed with:
MilliporeSigma’s leading brand, Milli-Q® water, has become synonymous with ultrapure lab water, and is the most cited brand in peer-reviewed publications. Milli-Q® systems have purification media that are tested and designed exclusively for MilliporeSigma, allowing the company to provide the best water quality to labs across the world.
MilliporeSigma’s Milli-Q® IQ 7000 system is the first product in an offering that will replace the existing bench-top Milli-Q® Advantage A10 systems. It will be available for purchase in April 2017.
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has some 21,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Udit Batra is the global chief executive officer of MilliporeSigma.
Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of €14.8 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck, KGaA, Darmstadt, Germany, visit www.emdgroup.com.